chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT DESCRIBED HANDS FEELING LOCKED IN POSITIONS, EYE SENSITIVITY DESCRIBED AS BRIGHTNESS AND FEELING WARM. IT HAPPENED A FEW MINUTES AFTER SITTING ON CHAIR. HE SAID HE FELT BETTER AND WENT AWAY ON ITS OWN BUT THOUGHT HE SHOULD LET THE PHARMACIST KNOW. HE SAID HAD NOT EATEN YET EITHER. HE DID NOT WANT TO WAIT ANY LONGER AT PHARMACY UPON RECOMMENDATION AND WOULD LET PHARMACY KNOW IF ANYTHING ELSE HAPPENS AND/OR WILL GET IMMEDIATE CARE IF NECESSARY.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX (lot# and route not provided) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, A pharmacist administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related conditions. In 2017, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine, and suffered serious physical, emotional and economic damages as a result of the patient's injuries.  As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Dizziness, Blurred Vision, Tachycardia, Tingling  lips.
After 3 days of the Pfizer first dose I got covid-19.  I didn't have fever or difficulty breathing, but I had:  Extremely fatigued Body aches Headache loss of taste and smell Runny nose Nausea  Diarrhea
dose too early, first dose administered on 01/19/2021  Moderna  lot #: 012L20A
still having problems with severe muscle spams and cramps all over her body, eyes, under her tongue muscle, chin, arm and mainly legs; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 54 year-old female patient received bnt162b2 (BNT162B2), administration date 25Feb2022 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: H1n1 influenza virus for Immunization, reaction(s): "anaphylaxis". The following information was reported: MUSCLE SPASMS (non-serious) with onset 2022, outcome "not recovered", described as "still having problems with severe muscle spams and cramps all over her body, eyes, under her tongue muscle, chin, arm and mainly legs". Therapeutic measures were taken as a result of muscle spasms.  Additional information: Caller had her first dose of the Pfizer BioNTech COVID-19 vaccine last 25Feb2022. Caller stated that she "is still having problems with severe muscle spams and cramps all over her body, eyes, under her tongue muscle, chin, arm and mainly legs". Caller also stated that her side effects "have not subsided and she was given Magnesium". Caller also mentioned that she "had problems with vaccines as she had anaphylaxis with H1N1 vaccine". Since she had a previous side effect, caller is worried in getting the second dose.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Left arm could not touch between shoulder and elbow without severe pain and the 5th day uncotraollable runs, fatigue and weakness
On 1/3 around 2 am , I got up to get something to eat and drink. The taste of food , feels/ taste like cotton on the left side of my mouth/ tongue.  As the day progress, I noticed I am having numbness left side of my face and mouth, unable to sip from a straw on the left side of my mouth, I am having facial droop that prompted me to to the ER . At ER same day my left eye is not blinking as my right eye. I was prescribed to take antiviral , steroids and eye meds.  TODAY-  1/4/21, I am still having same symptoms and my left eye , feels grainy/ needle pricking inside. Left eye vision more blurry.
On 11/8/2021, patient was given 0.5 mL of Moderna COVID-19 vaccine intramuscular in the right deltoid. This was the first dose. Vial was set to expire 11/6/2021. Patient was also 17. Patient was monitored for 30 minutes after injection and was stable prior to discharge. Patient was notified of incident and was informed she will continue to be contacted with additional information as it is received.
Gave a HIB vaccine to a 4 year old who had completed her primary series.  No adverse reactions.
Information has been received from a physician concerning a 25 year old female with PENICILLIN allergy who on 25-SEP-2008 was vaccinated with a third dose of 0.5mL RECOMBIVAX HB (lot# 660951/0398X).  Concomitant therapy included hormonal contraceptives (unspecified).  On 28-SEP-2008 the patient developed pain at injection site.  The pain later moved up her arm into her shoulder.  The patient described it as "arthritis pain".  Medical attention was sought.  The patient went to the emergency room but was not admitted to the hospital.  The patient was treated with ALEVE.  The patient did not report an adverse event after either of the first two shots.  The adverse events improved after stopping therapy.  At the time of reporting the patient was recovering.  Additional information has been requested.
sore arm; dizziness; stinging,/pain to the point of tears; burning; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (stinging,/pain to the point of tears), PAIN IN EXTREMITY (sore arm), BURNING SENSATION (burning) and DIZZINESS (dizziness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Celiac disease.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN (stinging,/pain to the point of tears) and BURNING SENSATION (burning). On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and DIZZINESS (dizziness). At the time of the report, PAIN (stinging,/pain to the point of tears), PAIN IN EXTREMITY (sore arm), BURNING SENSATION (burning) and DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient took expired Dramamine for her dizziness and it was helpful.
Extreme fatigue, chills, injection site pain,headache, entire arm sore including muscles and joints, dizziness, fever, general sick feeling. Started the next morning, lasted all day and was gone the next day, except for my arm still sore.
Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site) had not resolved. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medications reported by investigator o No treatment medications provided by the reporter.    This case was linked to US-MODERNATX, INC.-MOD-2021-033154 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-033154:Patient case for second dose
Pt received Pfizer Covid vaccine 8-1-21 at another facility. We did not know this at the time we administered the Moderna on 8-15-21 and the patient informed staff that he had never received a Covid vaccine before. This was brought to my attention by an RPh as she checked the database when pt presented to her location on 8-22-21 to receive his second dose of Pfizer vaccine. This thus constitutes the second dose in the series being administered too soon as well as being administered with the wrong brand. (We would not have done this if we had known about the first dose being administered elsewhere). I spoke with the patient 8-22-21 and he stated he had not had any adverse effects other than mild flu-like symptoms. I advised him the series is considered complete now.
Patient received covid moderna vaccine at 9:50am. While sitting in lobby after receiving vaccination at 10:00am, patient's husband reported that the patient was having difficulty breathing. Patient said "can't breathe." Pharmacist asked patient for consent to administer epi-pen. Pharmacist administered epi-pen 0.3mg to patient's outer thigh. After administering epipen, patient's symptoms resolved and patient stated that she felt better. Patient sat in waiting room to be observed. Pharmacist called patient's primary physician to inform them about the reaction and see about following up. Physician instructed for patient to report to the local emergency room.
First one just chills and fever. The second one body aches, fever, shills with sweating, nausea, vomiting and lasted 3 days. Went to bed the 30th and woke up in a drenched bed from seating.
Hives on same arm as injection.  Located on right shoulder, forearm, and deltoid area.  Severe itching.  Used cortisone cream without relief.  Hives still present on report date. (5 days later)
I thought I had a cold-stuffy nose and cough, around the 30th of May, while I was traveling. I was tested for COVID-19 before we flew home on the 1st of June and it was negative. On June 2nd I started feeling worse, my chest was tight and trouble breathing and couldn't breathe out of my nose. On the same day, I took a home and it was positive. So, I went to the clinic and was tested there and it was also, positive. June 2nd or 3rd I texted my doctor and she prescribed me PAXLOVID. I picked up my prescriptions and the mediation began working right away and helped a lot. My symptoms lasted 6 days.
This spontaneous report as received from a pharmacist refers to a 62 year old female patient with no pertinent medical history and drug reactions/allergies. On 10-MAY-2014 the patient was vaccinated with a 0.65ml dose of ZOSTAVAX (lot#J011828/Exp date 12/26/2014) subcutaneous for prevention of shingles. Injection location was not reported. On 10-MAY-2014, the patient experienced a red, swollen, and oval shaped reaction (about three inches in diameter) around the injection site after receiving ZOSTAVAX. Pharmacist reported that patient did not experience any itching or irritation at injection site. The patient saw pharmacist for medical attention. The outcome of the event was unknown. The causality of the event and ZOSTAVAX was unknown. Additional information has been requested.
On 1/14/2021 client started experiencing a red, hot rash around vaccine site as well as muscle tension and pain. No prior side effects before this day despite being vaccinated on 1/7/2021. Encouraged the client to seek care from his PCP or urgent care.
On April 24, 2021, within an hour of getting home after getting my vaccine I started my period.  I hadn't had one in ten months. I was bleeding for two weeks. I had bad cramps, pain, and really fatigued. I reached out to my doctor. I told her over the phone that I needed to see her because I was bleeding for two weeks, and I was having big blood clots. I was able to see the doctor on July 30, 2021, she did a pap smear, and bloodwork. It showed that my HSV1 antibodies were high, and it came back as positive. Pap smear came back normal. This also happened when I received the second dose.
pt recvd vax;subsequently exp n, v, dehydration, soreness, redness at inject site;
Post vax the patient developed a fever of 102.4F. The patient was treated with Tylenol and the fever dropped to 101F. The patient was fussy, sleeping more, and not eating well. A macular rash on the back and neck were noticed on 05/17/2001. The fever lasted until the evening of 05/17/2001.
passing out, heart palpatations, sharp stabs, fatigue, chest pain, dizziness, shortness of breathe  Pericarditis  Mitigare, Naproxen
The patient is an 18 month old who was brought in with episodes of tonoclonic seizures each lasting two minutes. He had three of these episodes in a period of two days. The patient had experienced a minor head injury during play at home. There was no described loss of consciousness at the time. He had seen at the time, i.e. a day prior to hospitalization in the ER and a CAT scan was essentially normal with artifact having been noted. Observed and noted to be stable after three hours and then was discharged home. He was admitted on presentation to the ER following three episodes of seizures. Physical exam showed stable vital signs and unremarkable neurologic exam. There was noted a small contusion in the right infraorbital area. Please see the admitting history and physical for details. Hospital course: the patient was admitted to the acute care unit and monitored. Neurology consultation was obtained and felt that evaluation with MRI and EEG were both normal. Neurosurgical consultation was done and seizure was thought probably idiopathic in origin. Advice by neurology has been to monitor and observe with no intervention and to arrange for further follow-up as an out patient. The patient was noted to have had an episode of vomiting and diarrhea also on admission. Subsequently, had been tolerating diet well with no more vomiting or diarrhea. Hydration status has remained adequate. Discharge condition is stable. Discharge diet regular. Medications none. Activity: regular. Disposition: to follow-up with own pediatrician in one week and with neurology in one month by appointments.
This spontaneous report as received from a health care professional referring to a 13 month old white female patient with none preexisting allergies, birth defects, medical conditions and illness at the time of vaccination and none adverse events following prior vaccination. On 29-AUG-2013 at 11:00 AM, the patient was vaccinated with M-M-R II, lot #H018947, expiration date 18-OCT-2014, dose 1 in the right vastus lateralis (RVL) and VARIVAX lot # J003541, expiration date 25-MAR-2015, dose 1 in the left vastus lateralis (LVL), indication, dose and route for both vaccines were not reported. The vaccines were stored at an unknown temperature for an unknown period of time. Concomitant therapies included PREVNAR lot #G43220, dose 4 in the RVL on 29-AUG-2013 at 11:00 AM, and HAVRIS jot #JR737 dose 1 in the LVL on the same day at 11:02 AM. Indication, dose and route for both vaccines were not reported. On 29-AUG-2013, patient was seen for her well child exam. On 03-SEP-2013, patient returned to the clinic with a mild rash. On 16-SEP-2013, patient returned again covered head to toe with a raised non-papular rash, fussy, mildly febrile and runny nose. The patient was diagnosed with varicella as a result of an unspecified diagnostic test. Patient received treatment with BENADRYL liquid, TYLENOL for fever and cool tepid baths. The outcome of the events was reporting as recovering. This is one of several reports from same source. Additional information is not expected.
injection site was swollen; area underneath her armpit was extremely swollen; achy; tired; headache; slept because of the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 20Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 21Oct2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "injection site was swollen"; SWELLING (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "area underneath her armpit was extremely swollen"; PAIN (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "achy"; FATIGUE (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "tired"; HEADACHE (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "headache"; SOMNOLENCE (non-serious) with onset 20Feb2021, outcome "recovered" (Feb2021), described as "slept because of the vaccine".  Additional information: It was reported that the patient (age: 74, unit: unknown) had a fairly severe reaction after the shot. She mentioned that it lasted for 4 days (as reported), it started on 20Feb2021 and ended on 23Feb2021 or 24Feb2021. Patient was due for 2nd dose on Saturday and she heard that if a person had COVID once, they do not have to receive the 2nd dose, patient wanted to confirm if this is true.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient fainted and blacked out. Patient was seen in ER. Left arm was swollen from shoulder to forearm and warm and red. Patient says extremely painful and tender. ED doctor advised to take Diphenhydramine.
Hand numbness; Fatigue; Headache; Nausea; Tongue sores; Ear Pain; Arm Pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included probiotics nos (MANUFACTURER UNKNOWN) for unknown indication and start date. The patient had no allergies to food, medication or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient received COVID vaccine on 08/27/21. On 08/28/21 patient started to experience chest pain, headache, shortness of breath and blurred vision. Also had some weakness. She was taken to ED and assessed. Symptoms have slightly improved but continues to have headache and chest pain several days later.
chills; mild nausea; pallor; fatigue; LGT (100.5); This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A 10-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Jul2022 as dose 3 (booster), single (Lot number: FL8094) at the age of 10 years intramuscular, in left arm for covid-19 immunization. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE , prev dose product=COVID 19,, prev dose brand=Pfizer,, prev dose brand unknown=False,, prev dose lot unknown=True,, prev dose lot unknown reason=Not available/provided to reporter at the time of report completion,, prev dose dose number=1), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE , prev dose product=COVID 19,, prev dose brand=Pfizer,, prev dose brand unknown=False,, prev dose lot unknown=True,, prev dose lot unknown reason=Not available/provided to reporter at the time of report completion,, prev dose dose number=2), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 23Jul2022, outcome "recovered" (Jul2022), described as "LGT (100.5)"; CHILLS (non-serious) with onset 23Jul2022, outcome "recovered" (Jul2022); FATIGUE (non-serious) with onset 23Jul2022, outcome "recovered" (Jul2022); NAUSEA (non-serious) with onset 23Jul2022, outcome "recovered" (Jul2022), described as "mild nausea"; PALLOR (non-serious) with onset 23Jul2022, outcome "recovered" (Jul2022). Therapeutic measures were taken as a result of chills, nausea, pallor, fatigue, pyrexia.  Additional information: 20h after injection: chills, mild nausea, pallor, fatigue and LGT (100.5). Sx lasted 5h and resolved c rest and 300mg of ibuprofen. Patient did not receive any other vaccines in four weeks prior covid-19 immunisation. It was unknown if patient tested covid-19 post vaccination.
Pain in upper left arm that has never subsided after the vaccination.  Inability to raise arm above shoulder height.  Intermittent pain severe enough to wake me up at night, with intermittent pain in to neck and lower arm. Requested medical massage treatment which is now being carried out, although pain is still present three and a half months after shot.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 24-APR-2015, the patient was inadvertently vaccinated with a dose of (Merck) PROQUAD (dose, route, lot number and expiration date not reported) and a dose of (Merck) VARIVAX (dose, route, lot number and expiration date not reported). No adverse effects were reported. Additional information has been requested.
ON 7/1/00, pt broke out with rash and developed incessant crying, irritability with opisthotonos on 7/2/00. Seen in the clinic on 7/3/00, 7/5/00, 7/6/00 and in the ER on 7/8/00 due to persistent crying and poor oral intake. No fever. Transferred to another hospital 7/8/00. Crying and irritability relieved after spinal tap under GA. Diagnosis was abnormal brain anatomy and Seckel's syndrome.